The impact of melphalan conditioning and CD34+ cell dose and schedule on post-transplant outcomes in AL amyloidosis - Muchtar, Eli; Sanchorawala, Vaishali; Hassan, Hamza; Hegenbart, Ute; Schönland, Stefan; Lee, Hans C.; Qazilbash, Muzaffar; Kin, Andrew; Zonder, Jeffrey; Jacob, Eapen; Buadi, Francis; Dispenzieri, Angela; et al. (American journal of hematology, 2025)
Im Text ist "+" hochgestellt